This HTML5 document contains 56 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n12http://dx.doi.org/10.1016/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n8http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q37533048
rdf:type
wikibase:Item
schema:description
scientific article published on 25 June 2009 vedecký článok bilimsel makale wetenschappelijk artikel videnskabelig artikel наукова стаття, опублікована в червні 2009 artigo científico vetenskaplig artikel مقالة علمية نشرت في 25 يونيو 2009 wissenschaftlicher Artikel научни чланак article científic article scientifique artículu científicu espublizáu en 2009 articolo scientifico vědecký článek
p:P577
wds:Q37533048-9668E74C-58D4-4E16-8C2C-62CB4154CB67
wdt:P577
2009-06-25T00:00:00Z
p:P2093
wds:Q37533048-7CB7DE20-F4F5-4011-B844-989BCFDFBA07
wdt:P2093
Michael J Duffy
rdfs:label
Survivin: a new target for anti-cancer therapy Survivin: a new target for anti-cancer therapy Survivin: a new target for anti-cancer therapy
skos:prefLabel
Survivin: a new target for anti-cancer therapy Survivin: a new target for anti-cancer therapy Survivin: a new target for anti-cancer therapy
schema:name
Survivin: a new target for anti-cancer therapy Survivin: a new target for anti-cancer therapy Survivin: a new target for anti-cancer therapy
p:P50
wds:Q37533048-9C049953-CA8A-452C-9709-0E559CEB8A0F wds:Q37533048-16AC7745-F0F0-418B-B370-A270DA92BF75
wdt:P50
wd:Q47504264 wd:Q38523143
p:P1476
wds:Q37533048-C0761D68-63F4-4572-8B9A-15C527CC6D34
wdt:P1476
Survivin: a new target for anti-cancer therapy
p:P304
wds:Q37533048-665C5475-F386-427C-A9A6-E1CD0682F4FF
wdt:P304
553-562
p:P31
wds:Q37533048-9775fe66-4f52-4c0c-a483-ebd176f4fdb3 wds:Q37533048-6B738B5A-7F4C-4E17-BAD5-44F2B9B0B7F7
wdt:P31
wd:Q13442814 wd:Q7318358
p:P698
wds:Q37533048-A65BFE64-631C-4D36-8122-5A35C6BB2021
wdtn:P698
n8:19559538
wdt:P698
19559538
p:P1433
wds:Q37533048-F1005359-440A-4137-A3BF-1907170166C9
wdt:P1433
wd:Q1955762
p:P433
wds:Q37533048-F95586E4-5D6E-41A7-99E8-2600B1B13F0F
p:P478
wds:Q37533048-09AB5957-1797-485B-BF1E-235711148AE8
wdt:P433
7
wdt:P478
35
p:P356
wds:Q37533048-9EDE37B3-CFEB-4A19-97C3-BA6707BE31F5
wdtn:P356
n12:J.CTRV.2009.05.003
wdt:P356
10.1016/J.CTRV.2009.05.003
p:P8608
wds:Q37533048-70B01D19-3F24-4941-8446-2EBF174E7FBE
wdt:P8608
release_263h7zub2rexxepidwm3hy7vca